{"meta":{"query_hash":"7d482cf4dfc4","filters":{"venue":"Clinical Hematology International"},"cohort_total":11,"direct_labels_cover":0,"predictions_cover":11,"exported":11,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7d482cf4dfc4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Hematology+International"},"results":[{"id":"W2945103886","doi":"10.2991/chi.d.190316.003","title":"Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis","year":2019,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cumulative incidence; Busulfan; Anti-thymocyte globulin; Fludarabine; Internal medicine; Cyclophosphamide; Transplantation; Gastroenterology; Total body irradiation; Hematopoietic stem cell transplantation; Graft-versus-host disease; Myeloid leukemia; Myeloid; Surgery; Immunology; Chemotherapy","score_opus":0.020475116050254937,"score_gpt":0.31881242611115107,"score_spread":0.29833731006089614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945103886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848324,0.0009837257,0.00020087464,0.000017750004,0.000004549666,0.0000066911166,0.000032152206,0.0000069044504,0.0002640956],"genre_scores_gemma":[0.9994405,0.00024149958,0.000118130214,0.000021630516,0.000017082173,0.0000063330936,0.000106507825,0.000001425481,0.00004699962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962413,0.00017081932,0.000040540268,0.000041756608,0.00009668418,0.000026073069],"domain_scores_gemma":[0.99888915,0.00039799555,0.00047202245,0.00009622551,0.000059344813,0.0000853745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077098166,0.00016659305,0.000306084,0.00016318781,0.00011876928,0.00026806744,0.00012939717,0.00019532314,0.00038583364],"category_scores_gemma":[0.0016059582,0.00006631406,0.00021934207,0.00016640221,0.00036734153,0.00016432657,0.00010483818,0.000284573,0.000115145085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047900133,0.0028540334,0.46992013,0.0004818805,0.0006149566,0.0010106652,0.0003366069,0.005927726,0.06367644,0.0005015859,0.000830728,0.40594515],"study_design_scores_gemma":[0.00413606,0.19542955,0.71613103,0.00017210604,0.00087779725,0.008791659,0.00017732271,0.008285111,0.05805493,0.00068727357,0.007204798,0.00005247306],"about_ca_topic_score_codex":0.00013629315,"about_ca_topic_score_gemma":0.00012923896,"teacher_disagreement_score":0.00077098166,"about_ca_system_score_codex":0.00021213562,"about_ca_system_score_gemma":0.00026985735,"threshold_uncertainty_score":0.0040774345},"labels":[],"label_agreement":null},{"id":"W3009770027","doi":"10.2991/chi.d.200221.001","title":"The CD34<sup>+</sup> Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors","year":2020,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Vetenskapsrådet","keywords":"Stem cell; Haematopoiesis; CD34; Transplantation; Peripheral blood; Hematopoietic stem cell transplantation; Sibling; Hematopoietic cell; Biology; Immunology; Cancer research; Medicine; Cell biology; Internal medicine; Psychology","score_opus":0.029988286859375376,"score_gpt":0.29390997804612623,"score_spread":0.26392169118675085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009770027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987937,0.00057198567,0.00026246632,0.000040150528,0.0000048766683,0.00000790788,0.000030466159,0.0000032991493,0.00028511652],"genre_scores_gemma":[0.99956936,0.000075830736,0.00021211432,0.000029287425,0.0000140133425,0.0000050382596,0.00004463883,0.0000027131773,0.000046946454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991405,0.0005474605,0.00008466875,0.00006554972,0.000115225615,0.000046602352],"domain_scores_gemma":[0.9977107,0.0015455208,0.00039849963,0.0001204649,0.00004987123,0.00017487018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001419268,0.00020783792,0.00037130882,0.0002849273,0.00012352325,0.0003906601,0.00018637125,0.00033050732,0.0012490847],"category_scores_gemma":[0.002730907,0.0001466971,0.00036329974,0.0003356788,0.00040952742,0.00029389607,0.00022280667,0.00034441505,0.00026322276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010668158,0.00055508903,0.9152732,0.00010872909,0.00046723796,0.0008798037,0.00009481133,0.0031859032,0.027746884,0.00022649833,0.0003946001,0.040398974],"study_design_scores_gemma":[0.00046670515,0.013336072,0.9306409,0.000031074964,0.00054449943,0.004827808,0.00011736183,0.00387506,0.043492272,0.00059705455,0.002050853,0.000020348736],"about_ca_topic_score_codex":0.00009294807,"about_ca_topic_score_gemma":0.00015416964,"teacher_disagreement_score":0.001419268,"about_ca_system_score_codex":0.00020200478,"about_ca_system_score_gemma":0.00015551128,"threshold_uncertainty_score":0.007505834},"labels":[],"label_agreement":null},{"id":"W3026687938","doi":"10.2991/chi.d.200502.001","title":"Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma","year":2020,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Institute for Health and Care Research","keywords":"Medicine; Multiple myeloma; Autologous stem-cell transplantation; Stem cell; Maintenance therapy; Transplantation; Intensive care medicine; Disease; Oncology; Malignancy; Chemotherapy; Internal medicine","score_opus":0.09566178335813888,"score_gpt":0.4328981237115701,"score_spread":0.3372363403534312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026687938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002162551,0.9987961,0.00007689363,0.0001248645,0.0000858565,0.000006975868,0.00001644684,0.0000048742663,0.0006715829],"genre_scores_gemma":[0.0014174769,0.9977107,0.00018186569,0.00017098752,0.00007879003,0.000009670746,0.000040384988,0.0000013601353,0.00038882074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998416,0.00003575661,0.000028879198,0.00002216438,0.000057582703,0.000014108463],"domain_scores_gemma":[0.99979585,0.00010713258,0.00004117476,0.00000517506,0.000038612627,0.000012082833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004556022,0.0003922887,0.00089558284,0.0012449477,0.00017939621,0.00065459334,0.0005704758,0.00064858,0.0033155521],"category_scores_gemma":[0.00061224995,0.00012987123,0.0005922977,0.0008772233,0.00018940364,0.00070300035,0.0004052627,0.0010958074,0.0012080312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012514935,0.000069875794,0.00013465484,0.025213033,0.00015379004,0.00015405662,0.00005235752,0.00020397258,0.0016034035,0.0014565876,0.011098235,0.9597348],"study_design_scores_gemma":[0.000056417255,0.00033096562,0.001467487,0.010463096,0.00044978966,0.0020879025,0.00007126139,0.0001037223,0.0010852069,0.0013166165,0.98254967,0.000017871913],"about_ca_topic_score_codex":0.0006010477,"about_ca_topic_score_gemma":0.001391101,"teacher_disagreement_score":0.0033155521,"about_ca_system_score_codex":0.00031148177,"about_ca_system_score_gemma":0.0006034712,"threshold_uncertainty_score":0.01109159},"labels":[],"label_agreement":null},{"id":"W3152726386","doi":"10.2991/chi.k.210328.001","title":"Passive Immunity Should and Will Work for COVID-19 for Some Patients","year":2021,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Immunology; Avidity; Antibody; Context (archaeology); Immunotherapy; Vaccination; Immunity; Acquired immune system; Antigen; Medicine; Virology; Biology; Immune system","score_opus":0.2912391709128565,"score_gpt":0.5547998803569317,"score_spread":0.2635607094440752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152726386","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026474873,0.035253447,0.011993703,0.7575142,0.017094191,0.00037575216,0.00034643785,0.0014917859,0.14945568],"genre_scores_gemma":[0.24803455,0.01864343,0.020219589,0.55491364,0.024855642,0.00062164175,0.00064126897,0.00057692,0.13149332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981744,0.0006307729,0.00012699097,0.00026500807,0.00042746178,0.00037535574],"domain_scores_gemma":[0.9958138,0.0009819792,0.0005494231,0.0005302357,0.00068514276,0.0014393727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004484332,0.00043989933,0.0006940802,0.00030410144,0.002222711,0.0027802389,0.000714797,0.0042743143,0.022032782],"category_scores_gemma":[0.009085882,0.00021897617,0.000812789,0.00019801968,0.002193023,0.0030712336,0.0014814883,0.0053769476,0.014905572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006966593,0.00066027883,0.024387222,0.0008043399,0.00012446227,0.003557236,0.0016953185,0.00013387548,0.00818834,0.030821946,0.4059905,0.52293974],"study_design_scores_gemma":[0.00018877082,0.0006595561,0.0060085175,0.00060246984,0.00006239956,0.008360403,0.0006866525,0.00009950294,0.0019228163,0.013924293,0.967428,0.000056597393],"about_ca_topic_score_codex":0.0006029159,"about_ca_topic_score_gemma":0.0009831983,"teacher_disagreement_score":0.022032782,"about_ca_system_score_codex":0.0008528576,"about_ca_system_score_gemma":0.0020198277,"threshold_uncertainty_score":0.073706925},"labels":[],"label_agreement":null},{"id":"W4319216437","doi":"10.1007/s44228-023-00029-7","title":"Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period","year":2023,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Haematopoiesis; Medicine; Stem cell; Period (music); Hematopoietic stem cell transplantation; Sulfamethoxazole; Trimethoprim; Hematopoietic stem cell; Hematopoietic cell; Transplantation; Internal medicine; Biology; Antibiotics; Microbiology; Genetics","score_opus":0.055091639863059476,"score_gpt":0.3957306368019153,"score_spread":0.3406389969388558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319216437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796486,0.0016628557,0.00010121888,0.00004172174,0.0000066156135,0.000011481327,0.00003436493,0.0000037429008,0.00017306],"genre_scores_gemma":[0.9994067,0.00038105674,0.00007370321,0.00002943789,0.000020436117,0.000007235728,0.00004920675,7.170848e-7,0.00003143018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966073,0.000091367394,0.000051053474,0.000042629366,0.00010619898,0.000048049347],"domain_scores_gemma":[0.99869555,0.00024981497,0.00080057286,0.00003352844,0.000053478743,0.00016721331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007803526,0.00017078628,0.0003077859,0.00032216302,0.00020756085,0.00032543179,0.00017277194,0.0002245647,0.00067269086],"category_scores_gemma":[0.0014455154,0.000064539745,0.00026588785,0.00029947984,0.00022208557,0.0001999511,0.00015272552,0.00030657055,0.00011476932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003135252,0.00021983763,0.956556,0.00016214093,0.000102566715,0.0007326852,0.00008593864,0.00021073801,0.0053796107,0.000035286237,0.00021092742,0.03316895],"study_design_scores_gemma":[0.000112245245,0.008977472,0.98059237,0.00006981833,0.00015773029,0.005153477,0.000120856705,0.00036670736,0.003660498,0.000044433567,0.00073803467,0.0000062475406],"about_ca_topic_score_codex":0.00023465655,"about_ca_topic_score_gemma":0.0005546715,"teacher_disagreement_score":0.0007803526,"about_ca_system_score_codex":0.0002854725,"about_ca_system_score_gemma":0.00046668053,"threshold_uncertainty_score":0.004126966},"labels":[],"label_agreement":null},{"id":"W4365811103","doi":"10.1007/s44228-023-00036-8","title":"Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH)","year":2023,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hematology; Multiple myeloma; Medicine; Round table; Internal medicine; Immune thrombocytopenia; Clinical immunology; Oncology; Immunology; Computer science","score_opus":0.22146585949380115,"score_gpt":0.5320369763188361,"score_spread":0.3105711168250349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365811103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051986927,0.81045043,0.00030182404,0.10490566,0.07482968,0.000101925034,0.0002515553,0.00005823642,0.00858076],"genre_scores_gemma":[0.0044062813,0.84731096,0.0009662756,0.093764976,0.037753157,0.00021133928,0.00056594936,0.00003239908,0.01498878],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987136,0.0003436119,0.00012957906,0.000095425035,0.00048402126,0.00023388446],"domain_scores_gemma":[0.99734193,0.0008543739,0.00027413524,0.000043063348,0.000895377,0.00059104693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005484648,0.0006343077,0.0011026033,0.0014796216,0.00078410155,0.0037411419,0.0009425167,0.005856201,0.010885726],"category_scores_gemma":[0.0042341603,0.00035790825,0.001185906,0.0014083701,0.0006090024,0.0030558635,0.0016729732,0.0049582114,0.004454349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018514824,0.00008707551,0.00011628712,0.0052399365,0.00005536487,0.0001835041,0.00013306888,0.000086457636,0.0007187992,0.0048640794,0.71108156,0.27724868],"study_design_scores_gemma":[0.00002757721,0.00007732915,0.00035356678,0.0018124272,0.000033485452,0.00012908506,0.000060327413,0.000022712211,0.000099941455,0.0007620248,0.9966118,0.000009728257],"about_ca_topic_score_codex":0.0013070026,"about_ca_topic_score_gemma":0.003324459,"teacher_disagreement_score":0.010885726,"about_ca_system_score_codex":0.0020801579,"about_ca_system_score_gemma":0.0057253935,"threshold_uncertainty_score":0.03641635},"labels":[],"label_agreement":null},{"id":"W4390398427","doi":"10.46989/001c.91478","title":"A Case of Renal Iron Overload Associated with Cold Agglutinin Disease Successfully Managed by Rituximab","year":2023,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Blood groups and transfusion","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Cold agglutinin disease; Hemosiderosis; Rituximab; Medicine; Hemolysis; Disease; Internal medicine; Gastroenterology; Immunology; Anemia; Antibody; Autoimmune hemolytic anemia","score_opus":0.02774528278202889,"score_gpt":0.3438216643318829,"score_spread":0.316076381549854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390398427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92265826,0.017370801,0.00875268,0.015110019,0.0012571322,0.0005541563,0.00042639155,0.0004174338,0.033453036],"genre_scores_gemma":[0.9891461,0.0023030455,0.0023688888,0.0020406733,0.0020663233,0.000053832504,0.00010956555,0.000038230737,0.0018733414],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99860966,0.00023021559,0.00017039066,0.00023841893,0.00020859345,0.0005427308],"domain_scores_gemma":[0.99768794,0.00075248035,0.00036581673,0.00023684137,0.00014495243,0.00081196456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007369751,0.002258639,0.0018490824,0.0046064225,0.004526143,0.0025537957,0.0021045222,0.008060547,0.0028879712],"category_scores_gemma":[0.004083087,0.0014482492,0.0025404838,0.002501799,0.0024386586,0.0025295804,0.0022789976,0.00587744,0.001249892],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018836541,0.000030909712,0.0013357224,0.000013476796,0.0000061852325,0.9977303,0.00006112108,0.000044279917,0.00013412464,0.0001094232,0.00015806728,0.00035752857],"study_design_scores_gemma":[0.0000129825885,0.00003197329,0.0011612175,0.000014008037,0.000012591895,0.99781394,0.00007550822,0.0002145559,0.00018195026,0.00013853931,0.00033408919,0.000008709964],"about_ca_topic_score_codex":0.0035065198,"about_ca_topic_score_gemma":0.003816192,"teacher_disagreement_score":0.008060547,"about_ca_system_score_codex":0.0024540434,"about_ca_system_score_gemma":0.0016655552,"threshold_uncertainty_score":0.017805398},"labels":[],"label_agreement":null},{"id":"W4400898001","doi":"10.46989/001c.121371","title":"The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge","year":2024,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Multiple myeloma; Longitudinal study; Cohort; Medical record; Longitudinal data; Intensive care medicine; Internal medicine; Demography; Pathology","score_opus":0.20297133141172918,"score_gpt":0.5076096884930626,"score_spread":0.30463835708133347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400898001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8966983,0.0018885483,0.0040702354,0.0016395493,0.00009198134,0.0008111564,0.09074916,0.0001152585,0.0039358176],"genre_scores_gemma":[0.9297739,0.0008824738,0.0086959265,0.0013887895,0.00020269428,0.002777664,0.054135263,0.00008048908,0.0020626478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743193,0.0015801338,0.0002101396,0.0003357387,0.00024880152,0.00019337803],"domain_scores_gemma":[0.99169934,0.0017024905,0.0033787426,0.0016560206,0.000924341,0.0006390547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066860584,0.00047625593,0.0003595563,0.0016982033,0.00072998146,0.00088177546,0.00067674846,0.0007948856,0.002372078],"category_scores_gemma":[0.012572155,0.00033345292,0.00061747927,0.0019618024,0.00023069802,0.0010840963,0.0013445274,0.0009321768,0.0006067959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092144567,0.00018887417,0.98295516,0.000063723186,0.00041962395,0.00009910328,0.00022488886,0.00026969964,0.00016966357,0.0002979498,0.008596796,0.005793045],"study_design_scores_gemma":[0.00022412234,0.00035359708,0.98869276,0.00008397865,0.00014437233,0.00037929387,0.0002985459,0.0007948946,0.00011130893,0.00017752546,0.008714479,0.000025238878],"about_ca_topic_score_codex":0.0179465,"about_ca_topic_score_gemma":0.027423844,"teacher_disagreement_score":0.0179465,"about_ca_system_score_codex":0.0013468952,"about_ca_system_score_gemma":0.0013606222,"threshold_uncertainty_score":0.03568411},"labels":[],"label_agreement":null},{"id":"W4414960061","doi":"10.46989/001c.144582","title":"Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Multiple myeloma; Pomalidomide; Overall survival; Transplantation; Clinical trial; Autologous stem-cell transplantation; Developing country; Ixazomib; Lenalidomide","score_opus":0.22432945688594108,"score_gpt":0.5196438872827304,"score_spread":0.2953144303967893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414960061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041102497,0.9943743,0.0003802509,0.00020448463,0.000080914695,0.00013314777,0.0005236654,0.00001590193,0.000177169],"genre_scores_gemma":[0.18039988,0.81467324,0.001962533,0.0008413312,0.00018361339,0.0006854346,0.0010312748,0.00002685779,0.00019582431],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9907354,0.0044400315,0.0026845406,0.0008876164,0.00095457427,0.00029795378],"domain_scores_gemma":[0.98507035,0.010621534,0.0024824983,0.00044904184,0.0011847109,0.00019190926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013484956,0.0025975495,0.015288233,0.008030225,0.00054745347,0.003339142,0.0017722853,0.0017412258,0.0025313664],"category_scores_gemma":[0.026840016,0.001381462,0.03665586,0.009497351,0.0006049088,0.0014817105,0.0015892733,0.0016141328,0.00019976054],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009361888,0.000022377848,0.0050327936,0.28023568,0.6993863,0.000100734935,0.00007138921,0.0008081646,0.00014420328,0.00015071155,0.0006277187,0.012483709],"study_design_scores_gemma":[0.0002860902,0.00011086707,0.0039562252,0.020132476,0.9734547,0.000089090565,0.000041673717,0.00021400656,0.00007813606,0.00018732251,0.0014288386,0.000020506292],"about_ca_topic_score_codex":0.009768357,"about_ca_topic_score_gemma":0.019813735,"teacher_disagreement_score":0.015288233,"about_ca_system_score_codex":0.002905845,"about_ca_system_score_gemma":0.004130073,"threshold_uncertainty_score":0.07131612},"labels":[],"label_agreement":null},{"id":"W4415308306","doi":"10.46989/001c.145180","title":"Erdheim-Chester Disease in Adults: 11 Cases from a Canadian Rare Diseases Program","year":2025,"lang":"en","type":"article","venue":"Clinical Hematology International","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Arthritis Research Centre of Canada; Université de Sherbrooke; University of British Columbia; Horizon Health Network; Research Canada; Dalhousie University","funders":"","keywords":"Disease; Retrospective cohort study; Cohort; Rare disease; Multisystem disease; Cohort study","score_opus":0.02428072673334375,"score_gpt":0.3908707248782963,"score_spread":0.3665899981449526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415308306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161047,0.0010189787,0.0002687801,0.00033759323,0.000024433983,0.00015307064,0.00055435527,0.000015459542,0.0060168817],"genre_scores_gemma":[0.99716526,0.0009449941,0.0004162217,0.00027078652,0.000029295274,0.000016479771,0.00046057443,0.0000064738083,0.00068991754],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99937785,0.000022478096,0.00004930124,0.00009194159,0.0002326261,0.00022575943],"domain_scores_gemma":[0.99944824,0.000044828535,0.00011791761,0.000024428376,0.00014126423,0.00022327481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025227113,0.00059736613,0.00027331695,0.0015933295,0.0032095846,0.0008171947,0.0004928553,0.0005087684,0.0016235312],"category_scores_gemma":[0.00094129716,0.0003115073,0.0002509455,0.0021324635,0.0007992488,0.00024568645,0.0009444679,0.0004933571,0.00023426444],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007847453,0.00009390632,0.89233476,0.000066751745,0.000030320572,0.084253706,0.0019792796,0.00009712821,0.0013576556,0.00021912451,0.0022702727,0.017218547],"study_design_scores_gemma":[0.00002296127,0.00014259962,0.78753334,0.00013426601,0.000051780993,0.19784884,0.0047675646,0.0003059416,0.0004633666,0.00011881398,0.0085763475,0.00003414625],"about_ca_topic_score_codex":0.5936818,"about_ca_topic_score_gemma":0.7945166,"teacher_disagreement_score":0.4063182,"about_ca_system_score_codex":0.0054718894,"about_ca_system_score_gemma":0.0068630306,"threshold_uncertainty_score":0.81742215},"labels":[],"label_agreement":null},{"id":"W4417211817","doi":"10.46989/001c.150393","title":"Ramadan fasting and hematological disorders: clinical considerations, risks, and management strategies","year":2025,"lang":"en","type":"review","venue":"Clinical Hematology International","topic":"Dietary Effects on Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Pediatric Oncology Group","funders":"","keywords":"Anemia; Risk stratification; Intermittent fasting; Affect (linguistics); Thalassemia","score_opus":0.23259348352927312,"score_gpt":0.5474700114073268,"score_spread":0.31487652787805365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417211817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049879978,0.999278,0.000028809378,0.0002923033,0.000084044244,0.000002990924,0.0000071854333,0.000002257599,0.00025449233],"genre_scores_gemma":[0.0005199497,0.9988374,0.0001117606,0.00022776624,0.00012450483,0.000006766258,0.000018077457,6.9697694e-7,0.00015300226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996221,0.000101852136,0.00009412707,0.000050510753,0.00010448848,0.000026818641],"domain_scores_gemma":[0.9991346,0.00052758725,0.00013622559,0.000016584503,0.00014308309,0.000042001728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009877557,0.0008381978,0.0017206684,0.0023844424,0.00034669854,0.0012355014,0.001055194,0.0012642189,0.003893012],"category_scores_gemma":[0.0020444666,0.0003158028,0.0010628459,0.0017630283,0.00047683803,0.0013787866,0.00072145415,0.002189867,0.0008437113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017596925,0.000096488686,0.0003494569,0.044868063,0.00028974295,0.0002154002,0.0000960405,0.00027665743,0.00035859642,0.002732695,0.027701333,0.9228396],"study_design_scores_gemma":[0.00009222683,0.00019613944,0.002631615,0.054694757,0.0009396498,0.0027968336,0.0002329998,0.00021409706,0.00025074516,0.0043026484,0.9336028,0.000045296496],"about_ca_topic_score_codex":0.0017015517,"about_ca_topic_score_gemma":0.004191021,"teacher_disagreement_score":0.003893012,"about_ca_system_score_codex":0.0007734258,"about_ca_system_score_gemma":0.0014811441,"threshold_uncertainty_score":0.013023436},"labels":[],"label_agreement":null}]}